Abbott (ABT) Tops Q1 EPS by 10c, Offers FY Guidance
Get Alerts ABT Hot Sheet
Price: $107.28 +1.91%
EPS Growth %: -4.9%
Financial Fact:
Interest expense: 117M
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: -4.9%
Financial Fact:
Interest expense: 117M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q1 EPS of $1.45, $0.10 better than the analyst estimate of $1.35. Revenue for the quarter came in at $10.7 billion versus the consensus estimate of $9.94 billion.
GUIDANCE:
Abbott sees 2021 EPS of at least $5.00, versus the consensus of $4.37.
- Abbott projects full-year 2021 diluted earnings per share from continuing operations under GAAP of at least $3.74. Abbott forecasts specified items for the full-year 2021 of $1.26 primarily related to intangible amortization, expenses associated with acquisitions, restructuring and cost reduction initiatives and other net expenses. Excluding specified items, projected adjusted diluted earnings per share from continuing operations would be at least $5.00 for full-year 2021.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abbott Laboratories (ABT) narrows 2024 earnings guidance, shares slip
- American Express (AXP) down despite beating Q1 estimates on top and bottom lines
- Wipro (WIT) Tops Q1 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!